Chimeric autoantibody receptor T cells specifically eliminate Graves’ Disease autoreactive B cells
IntroductionChimeric antigen receptor (CAR) T cells have recently become an important treatment for hematological cancers by efficiently eliminating B cells. B cell depleting CAR T cells are also in clinical trials for their use in treating severe autoimmune diseases and have shown promise in patien...
Saved in:
| Main Authors: | Abigail Cheever, Hunter G. Lindsay, Chloe C. Kang, Mackenzie Hansen, Kimball Demars, Kim L. O’Neill, K. Scott Weber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1562662/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases
by: Isidora Protić-Rosić, et al.
Published: (2025-05-01) -
Pathogenesis of Graves’ Disease Determined Using Single-Cell Sequencing with Thyroid Autoantigen Peptide Stimulation in B Cells
by: Genki Kobayashi, et al.
Published: (2025-07-01) -
The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis
by: Roberto Lande, et al.
Published: (2025-04-01) -
Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
by: Luca Perico, et al.
Published: (2025-01-01) -
Anti-PGK1 antibodies in immuno-related pancytopenia
by: Shanfeng Hao, et al.
Published: (2025-12-01)